Published in Cytometry B Clin Cytom on March 01, 2008
Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands. PLoS One (2009) 1.20
Modeling flow cytometry data for cancer vaccine immune monitoring. Cancer Immunol Immunother (2010) 0.98
Has the rate of CD4 cell count decline before initiation of antiretroviral therapy changed over the course of the Dutch HIV epidemic among MSM? PLoS One (2013) 0.95
Quantification of cells with specific phenotypes I: determination of CD4+ cell count per microliter in reconstituted lyophilized human PBMC prelabeled with anti-CD4 FITC antibody. Cytometry A (2015) 0.75
Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst (2008) 5.74
Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience. J Clin Oncol (2006) 5.02
CGHcall: calling aberrations for array CGH tumor profiles. Bioinformatics (2007) 2.83
Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells. Blood (2010) 2.31
Cells meeting our immunophenotypic criteria of endothelial cells are large platelets. Cytometry B Clin Cytom (2007) 2.24
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study. J Clin Oncol (2013) 2.22
Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain (2010) 2.19
Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy. Brain (2014) 2.14
Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity. Mol Ther (2013) 1.89
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes. J Immunol (2004) 1.87
Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast Cancer Res Treat (2008) 1.74
Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. Br J Haematol (2010) 1.66
mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin Cancer Res (2011) 1.66
Circulating tumour cell detection on its way to routine diagnostic implementation? Eur J Cancer (2007) 1.37
Reduction of variation in T-cell subset enumeration among 55 laboratories using single-platform, three or four-color flow cytometry based on CD45 and SSC-based gating of lymphocytes. Cytometry (2002) 1.35
Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes Chromosomes Cancer (2008) 1.26
External quality assurance of circulating tumor cell enumeration using the CellSearch(®) system: a feasibility study. Cytometry B Clin Cytom (2010) 1.24
Considerations for the control of background fluorescence in clinical flow cytometry. Cytometry B Clin Cytom (2009) 1.22
Measuring Ag-specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer. Trends Immunol (2005) 1.20
KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue. Int J Cancer (2013) 1.16
Preprocessing and downstream analysis of microarray DNA copy number profiles. Brief Bioinform (2010) 1.16
Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146. Breast Cancer Res Treat (2010) 1.14
Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses. Clin Cancer Res (2003) 1.12
Genetic classification of oral and oropharyngeal carcinomas identifies subgroups with a different prognosis. Cell Oncol (2009) 1.10
Psychometric evaluation of health-related quality of life measures in women after different types of delivery. J Psychosom Res (2007) 1.09
Preferential HLA usage in the influenza virus-specific CTL response. J Immunol (2004) 1.08
Testing the prediction error difference between 2 predictors. Biostatistics (2009) 1.07
Critical role of flow cytometry in evaluating peripheral blood hematopoietic stem cell grafts. Cytometry A (2004) 1.04
CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression. Cytometry B Clin Cytom (2006) 1.04
New insights into fatigue and health-related quality of life after delivery. Acta Obstet Gynecol Scand (2007) 1.04
Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations. Cytometry B Clin Cytom (2008) 1.03
Flow cytometric immunophenotyping of cerebrospinal fluid. Curr Protoc Cytom (2008) 1.03
Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells. Cancer Immunol Immunother (2010) 1.03
A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood (2006) 1.02
Central memory CD4+ T cells dominate the normal cerebrospinal fluid. Cytometry B Clin Cytom (2011) 0.99
Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas. Cancer Res (2009) 0.96
Double umbilical cord blood transplantation: a study of early engraftment kinetics in leukocyte subsets using HLA-specific monoclonal antibodies. Biol Blood Marrow Transplant (2012) 0.95
Flow cytometric characterization of cerebrospinal fluid cells. Cytometry B Clin Cytom (2011) 0.95
Circulating tumor cells and sample size: the more, the better. J Clin Oncol (2010) 0.94
Clinical value of circulating endothelial cell detection in oncology. Drug Discov Today (2012) 0.92
Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer. Oncologist (2012) 0.91
Flow cytometric CD34+ stem cell enumeration: lessons from nine years' external quality assessment within the Benelux countries. Cytometry B Clin Cytom (2007) 0.90
Leucoencephalopathy with brainstem and spinal cord involvement and high lactate: quantitative magnetic resonance imaging. Brain (2011) 0.90
Circulating endothelial cells: a potential parameter of organ damage in sickle cell anemia? Blood Cells Mol Dis (2009) 0.90
Enumeration of antigen-specific CD8+ T lymphocytes by single-platform, HLA tetramer-based flow cytometry: a European multicenter evaluation. Cytometry B Clin Cytom (2004) 0.90
Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck. BMC Med Genomics (2009) 0.89
CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes. Cancer Lett (2011) 0.88
Resolution of EBV(+) CNS lymphoma with appearance of CSF EBV-specific T cells. Ann Neurol (2005) 0.87
Contamination of synthetic HuD protein spanning peptide pools with a CMV-encoded peptide. Cytometry A (2008) 0.86
Copy number gain at 8q12.1-q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas. Genes Chromosomes Cancer (2009) 0.86
International study on inter-reader variability for circulating tumor cells in breast cancer. Breast Cancer Res (2014) 0.86
RHD(T201R, F223V) cluster analysis in five different ethnic groups and serologic characterization of a new Ethiopian variant DARE, the DIII type 6, and the RHD(F223V). Transfusion (2006) 0.85
Flow cytometric HLA-B27 screening: cross-reactivity patterns of commercially available anti-HLA-B27 monoclonal antibodies with other HLA-B antigens. Cytometry B Clin Cytom (2003) 0.85
Analytical performance of a standardized single-platform MHC tetramer assay for the identification and enumeration of CMV-specific CD8+ T lymphocytes. Cytometry A (2008) 0.84
Transfusion-related acute lung injury reports in the Netherlands: an observational study. Transfusion (2009) 0.84
No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies. Cancer Immunol Immunother (2007) 0.84
To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic! Clin Cancer Res (2011) 0.83
Identification of lethal microRNAs specific for head and neck cancer. Clin Cancer Res (2013) 0.83
Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias. Cytometry B Clin Cytom (2006) 0.83
Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection. Int J Cancer (2011) 0.83
Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage. Thromb Haemost (2008) 0.83
Dissection of the CMV specific T-cell response is required for optimized cardiac transplant monitoring. J Med Virol (2008) 0.82
HLA-DQ2+ individuals are susceptible to Hu-Ab associated paraneoplastic neurological syndromes. J Neuroimmunol (2010) 0.82
On the origin of (CD105+) circulating endothelial cells. Thromb Haemost (2009) 0.81
External quality assessment of platelet serology and human platelet antigen genotyping: a 10-year review. Transfusion (2008) 0.81
The impact of impurities in synthetic peptides on the outcome of T-cell stimulation assays. Rapid Commun Mass Spectrom (2007) 0.80
Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis. Transfusion (2014) 0.80
Measuring antigen-specific immune responses, 2008 update. Cytometry A (2008) 0.80
RHC and RHc genotyping in different ethnic groups. Transfusion (2002) 0.80
Flow cytometric screening for the HLA-B27 antigen on peripheral blood lymphocytes. Curr Protoc Cytom (2005) 0.79
CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties. Stem Cell Res (2013) 0.79
HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia. BMC Cancer (2012) 0.79
Well being of obstetric patients on minimal blood transfusions (WOMB trial). BMC Pregnancy Childbirth (2010) 0.79
B and T cell imbalances in CSF of patients with Hu-antibody associated PNS. J Neuroimmunol (2008) 0.79
No evidence for the presence of HuD-specific T cells in the cerebrospinal fluid of patients with Hu-associated paraneoplastic neurological syndromes. J Neurol (2009) 0.79